Repligen Corp (RGEN) — 10-Q Filings
All 10-Q filings from Repligen Corp. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Repligen Swings to Profit, Revenue Jumps on Strong Product Sales
— Nov 4, 2025 Risk: medium
REPLIGEN CORP (RGEN) reported a significant turnaround in its financial performance for the three and nine months ended September 30, 2025. Total revenue for th -
Repligen Q2 Revenue Plunges 15.2%, Net Income Down 85.7%
— Aug 7, 2025 Risk: high
Repligen Corp (RGEN) reported a significant decline in revenue and net income for the second quarter ended June 30, 2025. Total revenue decreased by 15.2% to $1 -
Repligen Corp. Q1 2025: Revenue, Notes, and Risk Factors
— Apr 29, 2025 Risk: medium
Repligen Corp. reported its first quarter 2025 results, ending March 31, 2025. The company's financial performance includes details on sales revenue and royalty -
Repligen Corp. Files Q2 2024 10-Q
— Jul 30, 2024 Risk: medium
Repligen Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and business operations, including information relat -
Repligen Corp Files 10-Q for Period Ending March 31, 2024
— May 1, 2024 Risk: low
REPLIGEN CORP (RGEN) filed a Quarterly Report (10-Q) with the SEC on May 1, 2024. Repligen Corp filed a 10-Q report for the period ending March 31, 2024. The fi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX